• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自我报告与生物标志物数据中男男性行为者(MSM)HIV 暴露前预防(PrEP)服药依从性过度报告的预测因素。

Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.

机构信息

Department of Epidemiology, University of California Los Angeles, Los Angeles, CA, USA.

Population Council, New York, NY, USA.

出版信息

AIDS Behav. 2018 Apr;22(4):1174-1183. doi: 10.1007/s10461-017-1958-4.

DOI:10.1007/s10461-017-1958-4
PMID:29079950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6038811/
Abstract

Young men who have sex with men (YMSM) face a disproportionately high burden of HIV. Oral pre-exposure prophylaxis (PrEP) is effective in preventing HIV acquisition, but adherence to PrEP among YMSM may be inadequate. Medication adherence may be assessed via biomarkers, which are expensive and invasive, or via self-report through Audio Computer Assisted Self-Interview (ACASI), which may result in over-reporting of adherence. In this paper we assess the potential of a new method of self-report, the Interactive Questionnaire System (iQS), in validly estimating true adherence rates. PrEP adherence among 167 YMSM aged 15-23 was measured via dried blood spot (DBS), ACASI, and iQS twice over a 24-week study period. Both ACASI- and iQS-reported data revealed that over 40% of individuals self-reporting adequate PrEP adherence had DBS-estimated drug levels indicating inadequate adherence. Adjusted logistic repeated measures random intercept regression analyses indicated that younger YMSM had higher odds of over-reporting adherence than older YMSM-each 1 year increase in age was associated with 0.79 times the odds of over-reporting adherence (95% CI 0.63, 0.98; p value = 0.031), and being African American was associated with 3.22 times greater odds of over-reporting than non-African Americans (95% CI 1.51, 6.90; p-value = 0.0003). These results suggest that ACASI and iQS methods of self-report significantly overestimate true PrEP adherence rates among YMSM, and that the odds of over-reporting adherence may be affected by both age and race.

摘要

男男性行为者(MSM)面临着不成比例的高艾滋病毒负担。口服暴露前预防(PrEP)在预防艾滋病毒感染方面非常有效,但 MSM 对 PrEP 的依从性可能不足。药物依从性可以通过生物标志物来评估,生物标志物既昂贵又具侵入性,也可以通过音频计算机辅助自我访谈(ACASI)的自我报告来评估,而自我报告可能会导致对依从性的高估。在本文中,我们评估了一种新的自我报告方法——交互式问卷系统(iQS)在准确估计真实依从率方面的潜力。在一项为期 24 周的研究中,通过干血斑(DBS)、ACASI 和 iQS 两次测量了 167 名年龄在 15-23 岁的 MSM 的 PrEP 依从性。ACASI 和 iQS 报告的数据均显示,超过 40%的自我报告有足够 PrEP 依从性的个体的 DBS 估计药物水平表明依从性不足。调整后的逻辑重复测量随机截距回归分析表明,年轻的 MSM 比年长的 MSM 更有可能高估依从性——每增加 1 岁,高估依从性的几率就会增加 0.79 倍(95%CI 0.63, 0.98;p 值=0.031),非裔美国人比非裔美国人高估依从性的几率高出 3.22 倍(95%CI 1.51, 6.90;p 值=0.0003)。这些结果表明,ACASI 和 iQS 自我报告方法显著高估了 MSM 中真实 PrEP 依从率,并且高估依从性的几率可能受到年龄和种族的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1543/6038811/3ce491c2d12a/nihms916439f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1543/6038811/3ce491c2d12a/nihms916439f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1543/6038811/3ce491c2d12a/nihms916439f1.jpg

相似文献

1
Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.自我报告与生物标志物数据中男男性行为者(MSM)HIV 暴露前预防(PrEP)服药依从性过度报告的预测因素。
AIDS Behav. 2018 Apr;22(4):1174-1183. doi: 10.1007/s10461-017-1958-4.
2
Facilitators and Barriers to Pre-Exposure Prophylaxis Willingness Among Young Men Who Have Sex with Men Who Use Geosocial Networking Applications in California.加利福尼亚州使用地理社交网络应用程序的男男性行为者中暴露前预防意愿的促进因素和障碍
AIDS Patient Care STDS. 2017 Dec;31(12):517-527. doi: 10.1089/apc.2017.0082.
3
Use of Pre-exposure Prophylaxis (PrEP) in Young Men Who Have Sex with Men is Associated with Race, Sexual Risk Behavior and Peer Network Size.在男男性行为者中使用暴露前预防(PrEP)与种族、性风险行为及同伴网络规模有关。
AIDS Behav. 2017 May;21(5):1376-1382. doi: 10.1007/s10461-017-1739-0.
4
Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.暴露前预防(PrEP)的使用和无保护肛交:男男性行为者队列中风险补偿的证据。
J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):358-364. doi: 10.1097/QAI.0000000000001604.
5
Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.比较美国男男性行为青少年和年轻男性人群中对人类免疫缺陷病毒预防用药依从性的测量指标。
Clin Infect Dis. 2018 Jan 6;66(2):213-219. doi: 10.1093/cid/cix755.
6
Cascade analysis of awareness, willingness, uptake and adherence with regard to PrEP among young men who have sex with men (YMSM) in China: A comparison between students and non-students.中国男男性行为者(YMSM)中对暴露前预防(PrEP)的知晓、意愿、接受和依从性的级联分析:学生与非学生的比较
HIV Med. 2024 Jul;25(7):840-851. doi: 10.1111/hiv.13639. Epub 2024 Mar 27.
7
A qualitative exploration of how to support PrEP adherence among young men who have sex with men.一项关于如何支持男男性行为者中年轻人坚持使用 PrEP 的定性探索。
AIDS Care. 2024 Jun;36(6):732-743. doi: 10.1080/09540121.2023.2240070. Epub 2023 Sep 25.
8
A Pilot Randomized Controlled Trial of an mHealth Intervention to Improve PrEP Adherence Among Young Sexual Minority Men.一项改善年轻性少数男性人群中 PrEP 依从性的移动医疗干预措施的初步随机对照试验。
AIDS Behav. 2024 Aug;28(8):2804-2820. doi: 10.1007/s10461-024-04374-3. Epub 2024 May 31.
9
Barriers and facilitators to pre-exposure prophylaxis (PrEP) uptake and adherence among men who have sex with men (MSM) in Thailand: a qualitative study.泰国男男性行为者中预防用药(PrEP)的使用和坚持的障碍和促进因素:一项定性研究。
AIDS Care. 2024 Aug;36(8):1126-1134. doi: 10.1080/09540121.2024.2332443. Epub 2024 Apr 4.
10
Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in California.加利福尼亚州男男性行为者在线样本中注射型和按需型暴露前预防措施的可接受性。
LGBT Health. 2018 Aug/Sep;5(6):341-349. doi: 10.1089/lgbt.2017.0244. Epub 2018 Aug 17.

引用本文的文献

1
Comparison of Self-Reported Substance Use with Outcomes of Urine Testing among Men Who Have Sex with Men in Africa Participating in HPTN 075.在参与HPTN 075研究的非洲男男性行为者中,自我报告的物质使用情况与尿液检测结果的比较
AIDS Behav. 2025 Sep 13. doi: 10.1007/s10461-025-04832-6.
2
Characterizing the Role of Neighborhood Disadvantage in a Digital PrEP Intervention for Young Sexual and Gender Minority Men.描述社区劣势在针对年轻性少数和性别少数男性的数字预防艾滋病病毒暴露前用药干预中的作用。
AIDS Behav. 2025 Aug 29. doi: 10.1007/s10461-025-04860-2.
3
Performance of Adherence Measures for Oral, Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Systematic Review.

本文引用的文献

1
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.一项针对年轻男男性行为者的HIV暴露前预防示范项目及安全性研究。
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29. doi: 10.1097/QAI.0000000000001179.
2
Tenofovir-based preexposure prophylaxis for HIV infection among African women.基于替诺福韦的暴露前预防用于非洲女性的HIV感染
N Engl J Med. 2015 Feb 5;372(6):509-18. doi: 10.1056/NEJMoa1402269.
3
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.
基于替诺福韦的口服HIV暴露前预防依从性措施的效果:一项系统评价
AIDS Behav. 2025 May 6. doi: 10.1007/s10461-025-04741-8.
4
Neighborhood Disadvantage, Syndemic Conditions, and PrEP Non-Adherence in Young Sexual and Gender Minority Men.社区劣势、综合征候群状况与年轻性少数和性别少数男性的暴露前预防药物非依从性
AIDS Behav. 2025 May 6. doi: 10.1007/s10461-025-04722-x.
5
Comparing PrEP adherence via objective and self-reported measures among fishermen working on Lake Victoria, Kenya.在肯尼亚维多利亚湖工作的渔民中,通过客观测量和自我报告的方式比较暴露前预防(PrEP)的依从性。
AIDS Care. 2025 May;37(5):749-757. doi: 10.1080/09540121.2025.2484312. Epub 2025 Apr 16.
6
Absorbing Markov chain model of PrEP drug adherence to estimate adherence decay rate and probability distribution in clinical trials.用于估计临床试验中暴露前预防药物依从性衰减率和概率分布的吸收马尔可夫链模型。
J Theor Biol. 2025 May 7;604:112086. doi: 10.1016/j.jtbi.2025.112086. Epub 2025 Mar 13.
7
Studying the Digital Intervention Engagement-Mediated Relationship Between Intrapersonal Measures and Pre-Exposure Prophylaxis Adherence in Sexual and Gender Minority Youth: Secondary Analysis of a Randomized Controlled Trial.研究性少数和性别少数青年中人际测量与暴露前预防依从性之间的数字干预参与介导关系:一项随机对照试验的二次分析
J Med Internet Res. 2025 Jan 13;27:e57619. doi: 10.2196/57619.
8
Performance of indirect adherence measures for daily oral pre-exposure prophylaxis for HIV among adolescent men who have sex with men and transgender women in Brazil.巴西男男性行为者和跨性别女性中,针对每日口服HIV暴露前预防用药的间接依从性测量方法的效果评估
PLoS One. 2024 Dec 31;19(12):e0310861. doi: 10.1371/journal.pone.0310861. eCollection 2024.
9
Prepared, Protected, EmPowered (P3): Primary Results of a Randomized Controlled Trial Using a Social Networking, Gamification, and Coaching App to Promote Pre-exposure Prophylaxis (PrEP) Adherence for Sexual and Gender Minority (SGM) Youth Living in the United States.准备、保护、赋能(P3):一项随机对照试验的主要结果,该试验使用社交网络、游戏化和辅导应用程序来促进美国性少数和性别少数(SGM)青年的暴露前预防(PrEP)依从性
AIDS Behav. 2025 Feb;29(2):652-663. doi: 10.1007/s10461-024-04547-0. Epub 2024 Nov 12.
10
Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.药物检测与 HPTN069/ACTG5305 二期 PrEP 试验中自我报告的依从性。
AIDS Behav. 2024 Nov;28(11):3710-3718. doi: 10.1007/s10461-024-04451-7. Epub 2024 Jul 31.
FEM-PrEP:与每日口服研究产品用于暴露前预防的依从性相关的模式和因素。
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):324-31. doi: 10.1097/QAI.0000000000000158.
4
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.男男性行为者和男变女性别者中暴露前预防措施的采用情况、性行为及艾滋病毒发病率:一项队列研究
Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.
5
Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.暴露前预防的依从性:当前、新出现及预期的证据基础
Clin Infect Dis. 2014 Jul;59 Suppl 1(Suppl 1):S55-60. doi: 10.1093/cid/ciu266.
6
Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection.研究 iPrEx 安慰剂对照试验中的研究产品依从性测量:与药物检测的一致性。
J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):530-7. doi: 10.1097/QAI.0000000000000216.
7
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.男男性行为者中开展 HIV 暴露前预防(PrEP)试验的可接受性和可行性。
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):447-56. doi: 10.1097/QAI.0b013e3182801081.
8
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.采用 LC-MS/MS 定量检测干血斑中的替诺福韦和恩曲他滨。
J Pharm Biomed Anal. 2014 Jan;88:144-51. doi: 10.1016/j.jpba.2013.08.033. Epub 2013 Aug 31.
9
Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand.泰国清迈iPrEx研究中男男性行为者的一项HIV预防研究里药物依从性的促进因素和障碍
AIDS Care. 2013 Aug;25(8):961-7. doi: 10.1080/09540121.2012.748871. Epub 2012 Dec 19.
10
High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.高危人群中 HIV 暴露前预防措施接受度高,但在坚持和使用方面存在挑战:肯尼亚一项间歇性和每日 PrEP Ⅰ期试验中的定性研究结果
AIDS Behav. 2013 Jul;17(6):2162-72. doi: 10.1007/s10461-012-0317-8.